Moltzen; Ejner Knud

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moltzen; Ejner Knud.The latest application filed is for "phenyl-piperazine derivatives as serotonin reuptake inhibitors".

Company Profile

1.14.12

Moltzen; Ejner Knud - Gentofte DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors App 20210276966 - Ruhland; Thomas ; et al.	2021-09-09
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 10,844,029 - Ruhland , et al. November 24, 2	2020-11-24
Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors App 20180127389 - Ruhland; Thomas ; et al.	2018-05-10
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 9,708,280 - Ruhland , et al. July 18, 2	2017-07-18
Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors App 20160137620 - Ruhland; Thomas ; et al.	2016-05-19
Phenyl-piperazine Derivatives As Serotonin Reuptake Inhibitors App 20120302553 - Ruhland; Thomas ; et al.	2012-11-29
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 8,110,567 - Ruhland , et al. February 7, 2	2012-02-07
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 7,683,053 - Ruhland , et al. March 23, 2	2010-03-23
Heteroaryl derivates, their preparation and use Grant 7,393,845 - Rottlander , et al. July 1, 2	2008-07-01
Indole derivatives Grant 7,342,015 - Rottlander , et al. March 11, 2	2008-03-11
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 7,144,884 - Ruhland , et al. December 5, 2	2006-12-05
Phenyl-piperazine derivatives as serotonin reuptake inhibitors Grant 7,138,407 - Ruhland , et al. November 21, 2	2006-11-21
Compounds and their use as glycine transport inhibitors Grant 6,921,774 - Moltzen , et al. July 26, 2	2005-07-26
Indole and 2,3-dihydroindole derivatives, their preparation and use Grant 6,727,263 - Moltzen , et al. April 27, 2	2004-04-27
Substituted phenyl-piperazine derivatives, their preparation and use Grant 6,699,864 - Ruhland , et al. March 2, 2	2004-03-02
Novel compounds and their use as glycine transport inhibitors App 20030181445 - Moltzen, Ejner Knud ; et al.	2003-09-25
Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use Grant 6,596,722 - Moltzen , et al. July 22, 2	2003-07-22
Substituted phenyl-piperazine derivatives, their preparation and use App 20030125320 - Ruhland, Thomas ; et al.	2003-07-03
Novel heteroaryl derivatives, their preparation and use App 20030050306 - Ruhland, Thomas ; et al.	2003-03-13
Novel indole derivatives App 20030050307 - Ruhland, Thomas ; et al.	2003-03-13
Indole and 2,3-dihydroindole derivatives, their preparation and use App 20030018050 - Moltzen, Ejner Knud ; et al.	2003-01-23
Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use App 20020173512 - Moltzen, Ejner Knud ; et al.	2002-11-21
4,5,6, and 7-indole and indoline derivatives, their preparation and use App 20020128272 - Moltzen, Ejner Knud ; et al.	2002-09-12
Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use App 20020035113 - Moltzen, Ejner Knud ; et al.	2002-03-21
1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists Grant RE36,374 - Bogeso , et al. November 2, 1	1999-11-02
Phenyl indole compounds Grant 5,703,087 - Perregaard , et al. December 30, 1	1997-12-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.